Back
Sorrento Therapeutics, Inc. 10K Form
Sell
19
SRNE
Sorrento Therapeutics, Inc.
Last Price:
$0.0000
Seasonality Move:
42.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SRNE News And Ratings
See the #1 stock for the next 7 days that we like better than SRNE
SRNE Financial Statistics
Sales & Book Value
| Annual Sales: | $62.8M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $25.1M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Sorrento Therapeutics, Inc. Earnings Forecast
Key Sorrento Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 15 years for SRNE is 39.88%.
-
The Selling, General & Administrative Expenses for SRNE have been equal to 290.17% of Gross Profit Margin.
-
The Research & Development expenses have been 352.05% of Revenue.
-
The Net Earning history of SRNE is -919.42% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Sorrento Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SRNE |
| CUSIP: | 83587F |
| Website: | sorrentotherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SRNE Technical Analysis vs Fundamental Analysis
Sell
19
Sorrento Therapeutics, Inc. (SRNE)
is a Sell
Is Sorrento Therapeutics, Inc. a Buy or a Sell?
-
Sorrento Therapeutics, Inc. stock is rated a SellThe current Sorrento Therapeutics, Inc. [SRNE] share price is $0.0018. The Score for SRNE is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.